Literature DB >> 3612532

Selectivity of muscarinic antagonists in radioligand and in vivo experiments for the putative M1, M2 and M3 receptors.

H N Doods, M J Mathy, D Davidesko, K J van Charldorp, A de Jonge, P A van Zwieten.   

Abstract

In the present study we investigated the nature of the muscarinic receptors present in the hippocampus, sympathetic ganglia, atria and salivary glands of the rat. The heterogeneity of the muscarinic receptors was examined both in vivo and in radioligand binding experiments. To study whether the receptors present in the investigated tissues are indeed distinct subtypes we determined the potencies of antagonists in both systems. It is proposed that there are three different binding sites present in hippocampal, atrial and submandibular membranes and we suggest to classify them as M1, M2 and M3, respectively. Both in vivo and in vitro pirenzepine appears to possess high affinity for M1 receptors, whereas 4-diphenylacetoxy-N-methylpiperidine methobromide and dicyclomine show high affinity for both M1 and M3 receptors. AF-DX 116 (11-2[[2-[(diethylamino)methyl]-1-piperidinyl]acetyl]-5, 11-dihydro-6H-pyrido[2,3-b][1,4]benzodiazepine-6-one) displayed high affinity for M2 receptors.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3612532

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  89 in total

1.  Muscarinic agonist potencies at three different effector systems linked to the M(2) or M(3) receptor in longitudinal smooth muscle of guinea-pig small intestine.

Authors:  H Okamoto; S A Prestwich; S Asai; T Unno; T B Bolton; S Komori
Journal:  Br J Pharmacol       Date:  2002-04       Impact factor: 8.739

2.  Receptor binding studies of soft anticholinergic agents.

Authors:  F Huang; P Buchwald; C E Browne; H H Farag; W M Wu; F Ji; G Hochhaus; N Bodor
Journal:  AAPS PharmSci       Date:  2001

Review 3.  Muscarinic receptor subtypes: implications for lung disease.

Authors:  P J Barnes
Journal:  Thorax       Date:  1989-03       Impact factor: 9.139

4.  Telenzepine inhibits electrically-stimulated, acetylcholine plus histamine-mediated acid secretion in the mouse isolated stomach by blockade of M1 muscarine receptors.

Authors:  W Kromer; E Baron; R Boer; M Eltze
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-01       Impact factor: 3.000

5.  The interaction of hexamethonium with muscarinic receptor subtypes in vitro.

Authors:  R M Eglen; A D Michel; C M Cornett; E A Kunysz; R L Whiting
Journal:  Br J Pharmacol       Date:  1989-10       Impact factor: 8.739

6.  Binding of muscarine receptor antagonists to pig coronary smooth muscle.

Authors:  I Rinner; H N Doods; K J van Charldorp; D Davidesko; P A van Zwieten
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-02       Impact factor: 3.000

7.  In vivo studies on receptor pharmacology of the human eccrine sweat gland.

Authors:  P A Low; T L Opfer-Gehrking; M Kihara
Journal:  Clin Auton Res       Date:  1992-02       Impact factor: 4.435

8.  Characterization of the muscarine receptor type on paracrine cells activated by McN-A-343 in the mouse isolated stomach.

Authors:  W Kromer; E Baron; M Beinborn; R Boer; M Eltze
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-03       Impact factor: 3.000

9.  Muscarine reduces inwardly rectifying potassium conductance in rat nucleus accumbens neurones.

Authors:  N Uchimura; R A North
Journal:  J Physiol       Date:  1990-03       Impact factor: 5.182

10.  Functional characterization of muscarinic receptors in murine airways.

Authors:  J Garssen; H Van Loveren; C M Gierveld; H Van der Vliet; F P Nijkamp
Journal:  Br J Pharmacol       Date:  1993-05       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.